Risk-Based Monitoring Approaches for Enhancing Quality and Efficiency in Oncology Clinical Trials

References

[1] Agrafiotis, D. K., Lobanov, V. S., Farnum, M. A., Yang, E., Ciervo, J., Walega, M., ... & Mackey, A. J. (2018). Risk-based monitoring of clinical trials: an integrative approach. Clinical therapeutics, 40(7), 1204-1212.

[2] Aldrighetti, R., Zennaro, I., Finco, S., & Battini, D. (2019). Healthcare supply chain simulation with disruption considerations: A case study from Northern Italy. Global Journal of Flexible Systems Management, 20(Suppl 1), 81-102.

[3] Alemayehu, C., Mitchell, G., & Nikles, J. (2018). Barriers for conducting clinical trials in developing countries-a systematic review. International journal for equity in health, 17(1), 37.

[4] Alemayehu, C., Mitchell, G., & Nikles, J. (2018). Barriers for conducting clinical trials in developing countries-a systematic review. International journal for equity in health, 17(1), 37.

[5] Armstrong, A. W., Watson, A. J., Makredes, M., Frangos, J. E., Kimball, A. B., & Kvedar, J. C. (2009). Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Archives of dermatology, 145(11), 1230-1236.

[6] Armstrong, A. W., Watson, A. J., Makredes, M., Frangos, J. E., Kimball, A. B., & Kvedar, J. C. (2009). Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Archives of dermatology, 145(11), 1230-1236.

[7] Arora, N., Maurya, P. K., & Kacker, P. (2017). Translational research in drug discovery and development. In Translational Bioinformatics and Its Application (pp. 55-87). Dordrecht: Springer Netherlands.

[8] Arora, N., Maurya, P. K., & Kacker, P. (2017). Translational research in drug discovery and development. In Translational Bioinformatics and Its Application (pp. 55-87). Dordrecht: Springer Netherlands.

[9] Asi, Y. M., & Williams, C. (2018). The role of digital health in making progress toward Sustainable Development Goal (SDG) 3 in conflict-affected populations. International journal of medical informatics, 114, 114-120.

[10] Assefa, Y., Hill, P. S., Ulikpan, A., & Williams, O. D. (2017). Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?. Globalization and health, 13(1), 73.

[11] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Digital Health Technologies and Real-Time Surveillance Systems: Transforming Public Health Emergency Preparedness Through Data-Driven Decision Making.

[12] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Digital Health Technologies and Real-Time Surveillance Systems: Transforming Public Health Emergency Preparedness Through Data-Driven Decision Making.

[13] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Evaluating the Strategic Role of Economic Research in Supporting Financial Policy Decisions and Market Performance Metrics.

[14] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Evaluating the Strategic Role of Economic Research in Supporting Financial Policy Decisions and Market Performance Metrics.

[15] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Leveraging Big Data Analytics for Population Health Management: A Comparative Analysis of Predictive Modeling Approaches in Chronic Disease Prevention and Healthcare Resource Optimization.

[16] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Leveraging Big Data Analytics for Population Health Management: A Comparative Analysis of Predictive Modeling Approaches in Chronic Disease Prevention and Healthcare Resource Optimization.

[17] Bam, L., McLaren, Z. M., Coetzee, E., & Von Leipzig, K. H. (2017). Reducing stock-outs of essential tuberculosis medicines: a system dynamics modelling approach to supply chain management. Health Policy and Planning, 32(8), 1127-1134.

[18] Barger, S., Sullivan, S. D., Bell-Brown, A., Bott, B., Ciccarella, A. M., Golenski, J., ... & Ramsey, S. D. (2019). Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care. BMC Medical Research Methodology, 19(1), 119.

[19] Barger, S., Sullivan, S. D., Bell-Brown, A., Bott, B., Ciccarella, A. M., Golenski, J., ... & Ramsey, S. D. (2019). Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care. BMC Medical Research Methodology, 19(1), 119.

[20] Beran, D., Zar, H. J., Perrin, C., Menezes, A. M., & Burney, P. (2015). Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. The Lancet Respiratory Medicine, 3(2), 159-170.

[21] Bhatt, A. (2011). Quality of clinical trials: A moving target. Perspectives in clinical research, 2(4), 124-128.

[22] Bhatt, A. (2011). Quality of clinical trials: A moving target. Perspectives in clinical research, 2(4), 124-128.

[23] Bizzo, B. C., Almeida, R. R., Michalski, M. H., & Alkasab, T. K. (2019). Artificial intelligence and clinical decision support for radiologists and referring providers. Journal of the American College of Radiology, 16(9), 1351-1356.

[24] Blasimme, A., & Vayena, E. (2019). The ethics of AI in biomedical research, patient care and public health. Patient Care and Public Health (April 9, 2019). Oxford Handbook of Ethics of Artificial Intelligence, Forthcoming.

[25] Bowman, S. (2013). Impact of electronic health record systems on information integrity: quality and safety implications. Perspectives in health information management, 10(Fall), 1c.

[26] Bowman, S. (2013). Impact of electronic health record systems on information integrity: quality and safety implications. Perspectives in health information management, 10(Fall), 1c.

[27] Boyer, A. P., Fair, A. M., Joosten, Y. A., Dolor, R. J., Williams, N. A., Sherden, L., ... & Wilkins, C. H. (2018). A multilevel approach to stakeholder engagement in the formulation of a clinical data research network. Medical Care, 56, S22-S26.

[28] Boyer, A. P., Fair, A. M., Joosten, Y. A., Dolor, R. J., Williams, N. A., Sherden, L., ... & Wilkins, C. H. (2018). A multilevel approach to stakeholder engagement in the formulation of a clinical data research network. Medical Care, 56, S22-S26.

[29] Bradley, B. D., Jung, T., Tandon-Verma, A., Khoury, B., Chan, T. C., & Cheng, Y. L. (2017). Operations research in global health: a scoping review with a focus on the themes of health equity and impact. Health research policy and systems, 15(1), 32.

[30] Campbell, B. R., Ingersoll, K. S., Flickinger, T. E., & Dillingham, R. (2019). Bridging the digital health divide: toward equitable global access to mobile health interventions for people living with HIV. Expert review of anti-infective therapy, 17(3), 141-144.

[31] Chang, A., Schyve, P. M., Croteau, R. J., O’Leary, D. S., & Loeb, J. M. (2005). The JCAHO patient safety event taxonomy: a standardized terminology and classification schema for near misses and adverse events. International Journal for Quality in Health Care, 17(2), 95-105.

[32] Chang, A., Schyve, P. M., Croteau, R. J., O’Leary, D. S., & Loeb, J. M. (2005). The JCAHO patient safety event taxonomy: a standardized terminology and classification schema for near misses and adverse events. International Journal for Quality in Health Care, 17(2), 95-105.

[33] Chin, R., & Bairu, M. (Eds.). (2011). Global clinical trials: effective implementation and management. Academic Press.

[34] Chin, R., & Bairu, M. (Eds.). (2011). Global clinical trials: effective implementation and management. Academic Press.

[35] Chopra, M., Bhutta, Z., Blanc, D. C., Checchi, F., Gupta, A., Lemango, E. T., ... & Victora, C. G. (2019). Addressing the persistent inequities in immunization coverage. Bulletin of the World Health Organization, 98(2), 146.

[36] Cleaveland, S., Sharp, J., Abela-Ridder, B., Allan, K. J., Buza, J., Crump, J. A., ... & Halliday, J. E. B. (2017). One Health contributions towards more effective and equitable approaches to health in low-and middle-income countries. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1725), 20160168.

[37] De Souza, J. A., Hunt, B., Asirwa, F. C., Adebamowo, C., & Lopes, G. (2016). Global health equity: cancer care outcome disparities in high-, middle-, and low-income countries. Journal of Clinical Oncology, 34(1), 6-13.

[38] Desai, A. N., Kraemer, M. U., Bhatia, S., Cori, A., Nouvellet, P., Herringer, M., ... & Lassmann, B. (2019). Real-time epidemic forecasting: challenges and opportunities. Health security, 17(4), 268-275.

[39] Devarapu, K., Rahman, K., Kamisetty, A., & Narsina, D. (2019). MLOps-Driven Solutions for Real-Time Monitoring of Obesity and Its Impact on Heart Disease Risk: Enhancing Predictive Accuracy in Healthcare. International Journal of Reciprocal Symmetry and Theoretical Physics, 6, 43-55.

[40] Diani, C. A., Rock, A., & Moll, P. (2017). An evaluation of the effectiveness of a risk-based monitoring approach implemented with clinical trials involving implantable cardiac medical devices. Clinical Trials, 14(6), 575-583.

[41] Dimond, E. P., Zon, R. T., Weiner, B. J., St. Germain, D., Denicoff, A. M., Dempsey, K., ... & Grubbs, S. S. (2016). Recap: Clinical trial assessment of infrastructure matrix tool to improve the quality of research conduct in the community. Journal of Oncology Practice, 12(1), 63-64.

[42] Efferth, T., Saeed, M. E., Mirghani, E., Alim, A., Yassin, Z., Saeed, E., ... & Daak, S. (2017). Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget, 8(30), 50284.

[43] Efferth, T., Saeed, M. E., Mirghani, E., Alim, A., Yassin, Z., Saeed, E., ... & Daak, S. (2017). Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget, 8(30), 50284.

[44] Ellenberg, S. S., Fleming, T. R., & DeMets, D. L. (2019). Data monitoring committees in clinical trials: a practical perspective. John Wiley & Sons.

[45] Enna, S. J., & Williams, M. (2009). Defining the role of pharmacology in the emerging world of translational research. In Advances in pharmacology (Vol. 57, pp. 1-30). Academic Press.

[46] Enna, S. J., & Williams, M. (2009). Defining the role of pharmacology in the emerging world of translational research. In Advances in pharmacology (Vol. 57, pp. 1-30). Academic Press.

[47] Erickson, S. M., Wolcott, J., Corrigan, J. M., & Aspden, P. (Eds.). (2003). Patient safety: achieving a new standard for care.

[48] Essien, I. A., Cadet, E., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2019). Integrated governance, risk, and compliance framework for multi-cloud security and global regulatory alignment. IRE Journals, 3(3), 215–224.

[49] Essien, I. A., Cadet, E., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2019). Integrated governance, risk, and compliance framework for multi-cloud security and global regulatory alignment. IRE Journals, 3(3), 215–224.

[50] Fenlon, D., Chivers Seymour, K., Okamoto, I., Winter, J., Richardson, A., Addington-Hall, J., ... & Foster, C. (2013). Lessons learnt recruiting to a multi-site UK cohort study to explore recovery of health and well-being after colorectal cancer (CREW study). BMC medical research methodology, 13(1), 153.

[51] Fenlon, D., Chivers Seymour, K., Okamoto, I., Winter, J., Richardson, A., Addington-Hall, J., ... & Foster, C. (2013). Lessons learnt recruiting to a multi-site UK cohort study to explore recovery of health and well-being after colorectal cancer (CREW study). BMC medical research methodology, 13(1), 153.

[52] Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of clinical trials. springer.

[53] Gatla, T. R. (2019). A cutting-edge research on AI combating climate change: innovations and its impacts. INNOVATIONS, 6(09), 5.

[54] Goel, N. A., Alam, A. A., Eggert, E. M., & Acharya, S. (2017, July). Design and development of a customizable telemedicine platform for improving access to healthcare for underserved populations. In 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) (pp. 2658-2661). IEEE.

[55] Gong, Y., Kang, H., Wu, X., & Hua, L. (2017). Enhancing patient safety event reporting. Applied clinical informatics, 8(03), 893-909.

[56] Gronde, T. V. D., Uyl-de Groot, C. A., & Pieters, T. (2017). Addressing the challenge of high-priced prescription drugs in the era of precision medicine: a systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks. PloS one, 12(8), e0182613.

[57] Hamilton, A. B., & Yano, E. M. (2017). The importance of symbolic and engaged participation in evidence-based quality improvement in a complex integrated healthcare system: response to “The science of stakeholder engagement in research”. Translational behavioral medicine, 7(3), 492-494.

[58] Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., ... & Ali, M. K. (2017). Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA internal medicine, 177(12), 1808-1817.

[59] Hedt-Gauthier, B. L., Chilengi, R., Jackson, E., Michel, C., Napua, M., Odhiambo, J., & Bawah, A. (2017). Research capacity building integrated into PHIT projects: leveraging research and research funding to build national capacity. BMC health services research, 17(Suppl 3), 825.

[60] Hendricks-Ferguson, V. L., Cherven, B. O., Burns, D. S., Docherty, S. L., Phillips-Salimi, C. R., Roll, L., ... & Haase, J. E. (2013). Recruitment strategies and rates of a multi-site behavioral intervention for adolescents and young adults with cancer. Journal of Pediatric Health Care, 27(6), 434-442.

[61] Hodge, H., Carson, D., Carson, D., Newman, L., & Garrett, J. (2017). Using Internet technologies in rural communities to access services: The views of older people and service providers. Journal of Rural Studies, 54, 469-478.

[62] Hoffmann, B., & Rohe, J. (2010). Patient safety and error management: what causes adverse events and how can they be prevented?. Deutsches Arzteblatt International, 107(6), 92.

[63] Hopkins, J., Burns, E., & Eden, T. (2013). International twinning partnerships: an effective method of improving diagnosis, treatment and care for children with cancer in low-middle income countries. Journal of Cancer Policy, 1(1-2), e8-e19.

[64] Huang, H. C., Singh, B., Morton, D. P., Johnson, G. P., Clements, B., & Meyers, L. A. (2017). Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points. PloS one, 12(8), e0182720.

[65] Hungbo, A. Q., & Adeyemi, C. (2019). Laboratory Safety and Diagnostic Reliability Framework for Resource-Constrained Blood Bank Operations.

[66] Hungbo, A. Q., Adeyemi, C., & Ajayi, O. O. (2019). Power BI-Based Clinical Decision Support System for Evidence-Based Nurse Decision-Making.

[67] Hurley, C., Shiely, F., Power, J., Clarke, M., Eustace, J. A., Flanagan, E., & Kearney, P. M. (2016). Risk based monitoring (RBM) tools for clinical trials: a systematic review. Contemporary clinical trials, 51, 15-27.

[68] Ismail, A., Karusala, N., & Kumar, N. (2018). Bridging disconnected knowledges for community health. Proceedings of the ACM on Human-Computer Interaction, 2(CSCW), 1-27.

[69] Jacobsen, K. H., Aguirre, A. A., Bailey, C. L., Baranova, A. V., Crooks, A. T., Croitoru, A., ... & Agouris, P. (2016). Lessons from the Ebola outbreak: action items for emerging infectious disease preparedness and response. EcoHealth, 13(1), 200-212.

[70] Johnson, M. R., Kenworthy-Heinige, T., Beck, D. J., Asghar, A., Broussard, E. B., Bratcher, K., ... & Planeta, B. M. (2018). Research site mentoring: A novel approach to improving study recruitment. Contemporary clinical trials communications, 9, 172-177.

[71] K Gohagan, J., Brien, B., A Hasson, M., D Umbel, K., Bridgeman, B., S Kramer, B., ... & C Prorok, P. (2015). Comprehensive Quality Management (CQM) in the PLCO Trial. Reviews on Recent Clinical Trials, 10(3), 223-232.

[72] Khan, M. R. (2019). Application and impact of new technologies in the supply chain management during COVID-19 pandemic: a systematic literature review. Aldrighetti, R., Zennaro, I., Finco, S., Battini, D, 81-102.

[73] Kuupiel, D., Bawontuo, V., & Mashamba-Thompson, T. P. (2017). Improving the accessibility and efficiency of point-of-care diagnostics services in low-and middle-income countries: lean and agile supply chain management. Diagnostics, 7(4), 58.

[74] Leath, B. A., Dunn, L. W., Alsobrook, A., & Darden, M. L. (2018). Enhancing rural population health care access and outcomes through the telehealth EcoSystem™ model. Online journal of public health informatics, 10(2), e218.

[75] Lee, B. Y., Connor, D. L., Wateska, A. R., Norman, B. A., Rajgopal, J., Cakouros, B. E., ... & Brown, S. T. (2015). Landscaping the structures of GAVI country vaccine supply chains and testing the effects of radical redesign. Vaccine, 33(36), 4451-4458.

[76] Lee, B. Y., Haidari, L. A., Prosser, W., Connor, D. L., Bechtel, R., Dipuve, A., ... & Brown, S. T. (2016). Re-designing the Mozambique vaccine supply chain to improve access to vaccines. Vaccine, 34(41), 4998-5004.

[77] Lewis, S., Bloom, J., Rice, J., Naeim, A., & Shortell, S. (2014). Using teams to implement personalized health care across a multi-site breast cancer network. In Population Health Management in Health Care Organizations (pp. 71-94). Emerald Group Publishing Limited.

[78] Lim, J., Claypool, E., Norman, B. A., & Rajgopal, J. (2016). Coverage models to determine outreach vaccination center locations in low and middle income countries. Operations research for health care, 9, 40-48.

[79] Liu, Y., Nandita, M. D., Shankar, L. K., Kauczor, H. U., Trattnig, S., Collette, S., & Chiti, A. (2015). A risk management approach for imaging biomarker-driven clinical trials in oncology. The Lancet Oncology, 16(16), e622-e628.

[80] Macefield, R. C., Beswick, A. D., Blazeby, J. M., & Lane, J. A. (2013). A systematic review of on-site monitoring methods for health-care randomised controlled trials. Clinical Trials, 10(1), 104-124.

[81] Mackey, T. K., & Nayyar, G. (2017). A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert opinion on drug safety, 16(5), 587-602.

[82] Marda, V. (2018). Artificial intelligence policy in India: a framework for engaging the limits of data-driven decision-making. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 376(2133), 20180087.

[83] Mariscal, J., Mayne, G., Aneja, U., & Sorgner, A. (2019). Bridging the gender digital gap. Economics, 13(1), 20190009.

[84] Mercer, T., Chang, A. C., Fischer, L., Gardner, A., Kerubo, I., Tran, D. N., ... & Pastakia, S. (2019). Mitigating the burden of diabetes in Sub-Saharan Africa through an integrated diagonal health systems approach. Diabetes, metabolic syndrome and obesity: targets and therapy, 2261-2272.

[85] Metcalf, C. J. E., Tatem, A., Bjornstad, O. N., Lessler, J., O'reilly, K., Takahashi, S., ... & Grenfell, B. T. (2015). Transport networks and inequities in vaccination: remoteness shapes measles vaccine coverage and prospects for elimination across Africa. Epidemiology & Infection, 143(7), 1457-1466.

[86] Meyer, J. C., Schellack, N., Stokes, J., Lancaster, R., Zeeman, H., Defty, D., ... & Steel, G. (2017). Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study. Frontiers in pharmacology, 8, 751.

[87] Miah, S. J., Hasan, J., & Gammack, J. G. (2017). On-cloud healthcare clinic: an e-health consultancy approach for remote communities in a developing country. Telematics and Informatics, 34(1), 311-322.

[88] Middleton, B., Bloomrosen, M., Dente, M. A., Hashmat, B., Koppel, R., Overhage, J. M., ... & Zhang, J. (2013). Enhancing patient safety and quality of care by improving the usability of electronic health record systems: recommendations from AMIA. Journal of the American Medical Informatics Association, 20(e1), e2-e8.

[89] Min, H. (2016). Global business analytics models: Concepts and applications in predictive, healthcare, supply chain, and finance analytics.

[90] Mohammadi, I., Wu, H., Turkcan, A., Toscos, T., & Doebbeling, B. N. (2018). Data analytics and modeling for appointment no-show in community health centers. Journal of primary care & community health, 9, 2150132718811692.

[91] Nascimento, R. C. R. M. D., Álvares, J., Guerra Junior, A. A., Gomes, I. C., Costa, E. A., Leite, S. N., ... & Acurcio, F. D. A. (2017). Availability of essential medicines in primary health care of the Brazilian Unified Health System. Revista de saude publica, 51, 10s.

[92] Nchinda, T. C. (2002). Research capacity strengthening in the South. Social science & medicine, 54(11), 1699-1711.

[93] Obodozie, O. O. (2012). Pharmacokinetics and drug interactions of herbal medicines: A missing critical step in the phytomedicine/drug development process. Reading in advanced pharmacokinetics-theory, methods, and applications. Croatia: InTech, 127-56.

[94] Olaniyan, M. F., Ale, S. A., & Uwaifo, F. (2019). Raw cucumber (Cucumis sativus) fruit juice as possible first-aid antidote in drug-induced toxicity. Recent Adv Biol Med, 5(2019), 10171.

[95] Olaniyan, M. F., Ojediran, T. B., Uwaifo, F., & Azeez, M. M. (2018). Host immune responses to mono-infections of Plasmodium spp., hepatitis B virus, and Mycobacterium tuberculosis as evidenced by blood complement 3, complement 5, tumor necrosis factor-α and interleukin-10: Host immune responses to monoinfections of Plasmodium spp., hepatitis B virus, and Mycobacterium tuberculosis. Community Acquired Infection, 5.

[96] Olaniyan, M. F., Uwaifo, F., & Ojediran, T. B. (2019). Possible viral immunochemical status of children with elevated blood fibrinogen in some herbal homes and hospitals in Nigeria. Environmental Disease, 4(3), 81-86.

[97] Olu, O., Muneene, D., Bataringaya, J. E., Nahimana, M. R., Ba, H., Turgeon, Y., ... & Dovlo, D. (2019). How can digital health technologies contribute to sustainable attainment of universal health coverage in Africa? A perspective. Frontiers in public health, 7, 341.

[98] Onyeji, G. N., & Sanusi, R. A. (2018). Diet quality of women of childbearing age in South-east Nigeria. Nutrition & Food Science, 48(2), 348-364.

[99] Paul, S., & Venkateswaran, J. (2018). Inventory management strategies for mitigating unfolding epidemics. IISE Transactions on Healthcare Systems Engineering, 8(3), 167-180.

[100] Perehudoff, S. K., Alexandrov, N. V., & Hogerzeil, H. V. (2019). The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries. PLoS One, 14(6), e0215577.

[101] Pillai, G., Chibale, K., Constable, E. C., Keller, A. N., Gutierrez, M. M., Mirza, F., ... & Kaiser, H. J. (2018). The Next Generation Scientist program: capacity-building for future scientific leaders in low-and middle-income countries. BMC Medical Education, 18(1), 233.

[102] Polater, A., & Demirdogen, O. (2018). An investigation of healthcare supply chain management and patient responsiveness: An application on public hospitals. International journal of pharmaceutical and healthcare marketing, 12(3), 325-347.

[103] Portnoy, A., Ozawa, S., Grewal, S., Norman, B. A., Rajgopal, J., Gorham, K. M., ... & Lee, B. Y. (2015). Costs of vaccine programs across 94 low-and middle-income countries. Vaccine, 33, A99-A108.

[104] Reddy, S., Fox, J., & Purohit, M. P. (2019). Artificial intelligence-enabled healthcare delivery. Journal of the Royal Society of Medicine, 112(1), 22-28.

[105] Rosemann, A. (2017). Challenges to international stem cell clinical trials in countries with diverging regulations. In Safety, ethics and regulations (pp. 301-319). Cham: Springer International Publishing.

[106] Roses, A. D. (2008). Pharmacogenetics in drug discovery and development: a translational perspective. Nature reviews Drug discovery, 7(10), 807-817.

[107] Roski, J., Hamilton, B. A., Chapman, W., Heffner, J., Trivedi, R., Del Fiol, G., ... & Pierce, J. (2019). How artificial intelligence is changing health and healthcare. Artificial intelligence in health care: The hope, the hype, the promise, the peril. Washington DC: National Academy of Medicine, 58.

[108] Sardar, P., Abbott, J. D., Kundu, A., Aronow, H. D., Granada, J. F., & Giri, J. (2019). Impact of artificial intelligence on interventional cardiology: from decision-making aid to advanced interventional procedure assistance. Cardiovascular interventions, 12(14), 1293-1303.

[109] Sayed, S., Cherniak, W., Lawler, M., Tan, S. Y., El Sadr, W., Wolf, N., ... & Fleming, K. A. (2018). Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions. The Lancet, 391(10133), 1939-1952.

[110] Selby, J. V., Grossman, C., Zirkle, M., & Barbash, S. (2018). Multistakeholder engagement in PCORnet, the national patient-centered clinical research network. Medical Care, 56, S4-S5.

[111] Shrestha, Y. R., Ben-Menahem, S. M., & Von Krogh, G. (2019). Organizational decision-making structures in the age of artificial intelligence. California management review, 61(4), 66-83.

[112] Shyur, L. F., & Yang, N. S. (2008). Metabolomics for phytomedicine research and drug development. Current opinion in chemical biology, 12(1), 66-71.

[113] Sim, S. Y., Jit, M., Constenla, D., Peters, D. H., & Hutubessy, R. C. (2019). A scoping review of investment cases for vaccines and immunization programs. Value in health, 22(8), 942-952.

[114] Smith, L., Tan, A., Stephens, J. D., Hibler, D., & Duffy, S. A. (2019). Overcoming challenges in multisite trials. Nursing research, 68(3), 227-236.

[115] Srivastava, S. C., & Shainesh, G. (2015). Bridging the service divide through digitally enabled service innovations. Mis Quarterly, 39(1), 245-268.

[116] Stanfill, M. H., & Marc, D. T. (2019). Health information management: implications of artificial intelligence on healthcare data and information management. Yearbook of medical informatics, 28(01), 056-064.

[117] Strusani, D., & Houngbonon, G. V. (2019). The role of artificial intelligence in supporting development in emerging markets. International Finance Corporation, Washington, DC.

[118] Taiwo, K. A. 2015: AI in population health: Scaling preventive models for age-related diseases in the United States. International Journal of Science and Research Archive, 2025, 16(01), 1240-1260. https://doi.org/10.30574/ijsra.2025.16.1.2015

[119] Thomford, N. E., Dzobo, K., Chimusa, E., Andrae-Marobela, K., Chirikure, S., Wonkam, A., & Dandara, C. (2018). Personalized herbal medicine? A roadmap for convergence of herbal and precision medicine biomarker innovations. OMICS: A Journal of Integrative Biology, 22(6), 375-391.

[120] Thornicroft, G., Cooper, S., Bortel, T. V., Kakuma, R., & Lund, C. (2012). Capacity building in global mental health research. Harvard review of psychiatry, 20(1), 13-24.

[121] Timmermans, C., Venet, D., & Burzykowski, T. (2016). Data-driven risk identification in phase III clinical trials using central statistical monitoring. International journal of clinical oncology, 21(1), 38-45.

[122] Ulrich-Merzenich, G., Panek, D., Zeitler, H., Wagner, H., & Vetter, H. (2009). New perspectives for synergy research with the “omic”-technologies. Phytomedicine, 16(6-7), 495-508.

[123] Utazi, C. E., Thorley, J., Alegana, V. A., Ferrari, M. J., Takahashi, S., Metcalf, C. J. E., ... & Tatem, A. J. (2019). Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies. Nature communications, 10(1), 1633.

[124] Uwaifo, F., Ngokere, A., Obi, E., Olaniyan, M., & Bankole, O. (2019). Histological and biochemical changes induced by ethanolic leaf extract of Moringa oleifera in the liver and lungs of adult wistar rats. Biomedical and Biotechnology Research Journal (BBRJ), 3(1), 57-60.

[125] Uwaifo, F., Obi, E., Ngokere, A., Olaniyan, M. F., Oladeinde, B. H., & Mudiaga, A. (2018). Histological and biochemical changes induced by ethanolic leaf extract of Moringa oleifera in the heart and kidneys of adult wistar rats. Imam Journal of Applied Sciences, 3(2), 59-62.

[126] Van Dam, J., Onyango, K. O., Midamba, B., Groosman, N., Hooper, N., Spector, J., ... & Ogutu, B. (2017). Open-source mobile digital platform for clinical trial data collection in low-resource settings. BMJ innovations, 3(1).

[127] Vogler, S., Paris, V., & Panteli, D. (2018). Ensuring access to medicines: How to redesign pricing, reimbursement and procurement? (p. 30272895). Copenhagen: World Health Organization, Regional Office for Europe.

[128] Wang, H., & Rosemberg, N. (2018). Universal health coverage in low-income countries: Tanzania’s efforts to overcome barriers to equitable health service access.

[129] Will, Y., McDuffie, J. E., Olaharski, A. J., & Jeffy, B. D. (Eds.). (2016). Drug discovery toxicology: from target assessment to translational biomarkers. John Wiley & Sons.

[130] Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., ... & Reich, M. R. (2017). Essential medicines for universal health coverage. The Lancet, 389(10067), 403-476.

[131] Zineh, I., & Woodcock, J. (2013). Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation. Clinical Pharmacology & Therapeutics, 93(6), 515-525.

@article{1710571,
      author = {Chisom Ezeanochie, Opeoluwa Oluwanifemi Ajayi, Christiana Adeyemi},
      title = {Risk-Based Monitoring Approaches for Enhancing Quality and Efficiency in Oncology Clinical Trials},
      journal = {Iconic Research And Engineering Journals},
      year = {2019},
      volume = {2},
      number = {7},
      pages = {192-213},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1710571.pdf},
      abstract = {Risk-based monitoring (RBM) has emerged as a transformative approach to improving the quality and efficiency of oncology clinical trials, where traditional monitoring methods often struggle with complexity, high costs, and operational inefficiencies. In oncology studies, characterized by large patient populations, multiple sites, and intricate therapeutic regimens, RBM provides a structured framework for focusing oversight on areas of highest risk while reducing unnecessary monitoring burden. By integrating centralized data review, key risk indicators (KRIs), and advanced statistical methods, RBM shifts the paradigm from exhaustive source data verification to proactive risk detection and mitigation. This abstract explores the role of RBM in enhancing clinical trial performance, particularly in oncology, by streamlining data integrity processes, improving patient safety oversight, and optimizing resource allocation. It emphasizes how data-driven insights derived from centralized monitoring enable early detection of protocol deviations, adverse events, and data anomalies, thereby ensuring regulatory compliance and patient protection. Additionally, RBM facilitates adaptive trial management by allowing continuous reassessment of monitoring strategies based on evolving trial risks, site performance, and patient recruitment trends. This flexibility is particularly valuable in oncology, where trials often involve complex endpoints, biomarker-driven subgroups, and long-term follow-up requirements. Evidence suggests that RBM can reduce monitoring costs, accelerate decision-making, and improve overall trial quality without compromising regulatory standards. Furthermore, RBM supports broader initiatives toward digital transformation in clinical research by leveraging real-time analytics, remote monitoring technologies, and risk visualization dashboards. These innovations enhance collaboration between sponsors, sites, and regulatory bodies, promoting transparency and accountability. Ultimately, risk-based monitoring is not merely a cost-containment strategy but a quality-driven framework that aligns with global regulatory guidance and the evolving needs of oncology research. Its implementation represents a critical step toward delivering robust, reliable, and patient-centered outcomes in cancer clinical trials, while ensuring efficiency in increasingly complex research environments.},
      keywords = {Risk-Based Monitoring, Oncology Clinical Trials, Quality Management, Data Integrity, Patient Safety, Efficiency, Centralized Monitoring, Key Risk Indicators, Regulatory Compliance, Adaptive Trial Management.},
      month = {January},
  }